The Enterprise Value as of November 2024 (TTM) for Aptorum Group Limited (APM) is 8.77M

According to Aptorum Group Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 8.77M. This represents a change of -28.76% compared to the average of 12.31M of the last 4 quarters.

Aptorum Group Limited (APM) Historical Enterprise Value (quarterly & annually)

How has APM Enterprise Value performed in the past?

The mean historical Enterprise Value of Aptorum Group Limited over the last ten years is 205.65M. The current 8.77M Enterprise Value has changed 326.30% with respect to the historical average. Over the past ten years (40 quarters), APM's Enterprise Value was at its highest in in the June 2019 quarter at 691.17M. The Enterprise Value was at its lowest in in the February 2023 quarter at 0.

Aptorum Group Limited (APM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aptorum Group Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptorum Group Limited (APM) Average Enterprise Value

How has APM Enterprise Value performed in the past?

The current Enterprise Value of Aptorum Group Limited (APM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptorum Group Limited (APM) Enterprise Value vs. Peers

How is APM’s Enterprise Value compared to its peers?

Aptorum Group Limited’s Enterprise Value is less than ERYTECH Pharma S.A. (43.57M), greater than Surrozen, Inc. (-334650.00), less than Unicycive Therapeutics, Inc. (50.19M), less than Armata Pharmaceuticals, Inc. (205.85M), greater than Applied Molecular Transport Inc. (-5743713.00), greater than Fresh Tracks Therapeutics, Inc. (-6447751.00), less than AIM ImmunoTech Inc. (15.64M), greater than BioCardia, Inc. (7.95M), less than Innate Pharma S.A. (101.14M), less than Addex Therapeutics Ltd (11.76M), greater than Celyad Oncology SA (902.27K), less than Dyadic International, Inc. (30.38M), greater than Altamira Therapeutics Ltd. (1.17M), greater than Dermata Therapeutics, Inc. (-3107527.00), greater than ContraFect Corporation (-1135867.00), greater than eFFECTOR Therapeutics, Inc. (3.64M), less than Aditxt, Inc. (12.22M), greater than NeuroBo Pharmaceuticals, Inc. (-6530026.00), greater than Revelation Biosciences, Inc. (-8887351.00),

Build a custom stock screener for Aptorum Group Limited (APM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptorum Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptorum Group Limited (APM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptorum Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.